Gluxit Trio 5/50/500 Tablet 15's
Rs. 194.72
Title
Gluxit Trio 5/50/500 Tablet 15's
Prescription drug
Expiry
:
31-08-2027
About: Gluxit Trio is a triple combination antidiabetic tablet for type 2 diabetes.
Usage Instructions: Taken once daily with main meal or as directed.
Benefits: Targets SGLT2, DPP‑4 and hepatic glucose pathways simultaneously for robust glycemic control.
How it Works: Likely contains dapagliflozin 5 mg, sitagliptin 50 mg and metformin 500 mg; dapagliflozin increases urinary glucose loss, sitagliptin enhances incretin‑mediated insulin secretion, metformin improves insulin sensitivity.
Side Effects: Genital infections, GI upset, headache, hypoglycemia risk when combined with other agents.
Safety Advice: Monitor renal function, blood sugar, and keep good hydration.
Storage: Store below 25–30°C.
Usage Instructions: Taken once daily with main meal or as directed.
Benefits: Targets SGLT2, DPP‑4 and hepatic glucose pathways simultaneously for robust glycemic control.
How it Works: Likely contains dapagliflozin 5 mg, sitagliptin 50 mg and metformin 500 mg; dapagliflozin increases urinary glucose loss, sitagliptin enhances incretin‑mediated insulin secretion, metformin improves insulin sensitivity.
Side Effects: Genital infections, GI upset, headache, hypoglycemia risk when combined with other agents.
Safety Advice: Monitor renal function, blood sugar, and keep good hydration.
Storage: Store below 25–30°C.
₹194.72
MRP: ₹216.36
Save ₹21.64
(10%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Gluxit Trio is a triple combination antidiabetic tablet for type 2 diabetes.
Usage Instructions: Taken once daily with main meal or as directed.
Benefits: Targets SGLT2, DPP‑4 and hepatic glucose pathways simultaneously for robust glycemic control.
How it Works: Likely contains dapagliflozin 5 mg, sitagliptin 50 mg and metformin 500 mg; dapagliflozin increases urinary glucose loss, sitagliptin enhances incretin‑mediated insulin secretion, metformin improves insulin sensitivity.
Side Effects: Genital infections, GI upset, headache, hypoglycemia risk when combined with other agents.
Safety Advice: Monitor renal function, blood sugar, and keep good hydration.
Storage: Store below 25–30°C.
Usage Instructions: Taken once daily with main meal or as directed.
Benefits: Targets SGLT2, DPP‑4 and hepatic glucose pathways simultaneously for robust glycemic control.
How it Works: Likely contains dapagliflozin 5 mg, sitagliptin 50 mg and metformin 500 mg; dapagliflozin increases urinary glucose loss, sitagliptin enhances incretin‑mediated insulin secretion, metformin improves insulin sensitivity.
Side Effects: Genital infections, GI upset, headache, hypoglycemia risk when combined with other agents.
Safety Advice: Monitor renal function, blood sugar, and keep good hydration.
Storage: Store below 25–30°C.